The biopharmaceutical company Pfizer offers a health care portfolio with some of the world’s best-known prescription medicines, vaccines and non-prescription products.
Pharmaceutical Packaging Professionals Pty Ltd (PPP) is a supporter of the Australian and international pharmaceutical, biotechnology and medical research sectors. PPP provide of GMP investigational product manufacturing, logistical services and distribute clinical supplies to Australia, New Zealand, Asia, North America and Europe.
PharmOut is an Australian head quartered international consultancy offering - GMP compliance, validation, training, architectural and engineering consulting services to the pharmaceutical, blood and tissue, pesticides and veterinary and medical device manufacturers, as well as related hospital and pharmacy operations.
Phillips Ormonde Fitzpatrick is a specialist intellectual property (IP) firm, offering a comprehensive range of services from conception to enforcement. They identify, protect, manage and enforce your IP assets, creating an IP strategy in line with commercial objectives.
Portal Surgical Procedures are currently developing an innovative, non-invasive, easy-to-use wound closure system that is designed enable full control of the surgical site before, during and after surgery. The system has many unique features with potential health and well-being advantages over traditional wound closure methods such as sutures; both in terms of reduced health care costs and improved patient outcomes.
PRAXIS Australia is an NFP/Charity, formed in mid-2015 as a result of the vision of its members, University of Sydney, Bellberry Ltd, and Monash University (through its partner, Global Reconciliation Ltd). The mission of PRAXIS is to enhance the understanding and practice of ethical research for the benefit of the broader community, which is achieved via the creation and application of various training and education models.
Prime is an accounting firm that has assisted companies obtain in excess of $250 million in R&D cash refunds for their R&D activities in and outside Australia.
PROHAB believe in thinking differently and leading rehabilitation and in collaboration with University partners and Elite Sport, they are breaking new ground in advanced manufacturing and artificial intelligence software. PROHAB is an Australian company who cares about making the best rehabilitation devices and services for Professional Sport, Healthcare, Fitness and Home Health.
Proteolytics Pty Ltd, based in Perth, is developing and commercialising OPAL-A, a proprietary botanical extract from paw paw fruit to treat hard-to-heal wounds for human and animal health.
Proteomics International (ASX: PIQ) is a medical technology company at the forefront of predictive diagnostics and bio-analytical services.
Q-Pharm is a state-of-the-art early-phase clinical trials company providing a broad range of high-quality services for commercial and academic clients from around the world.
QED Medical provides the medical device industry with regulatory, quality management and general product development advice.
Qlicksmart innovate and commercialise world class safety medical devices. They are passionate about workplace safety as a right of all workers and the responsibility of all employers, and design and develop safety devices to prevent injuries and improve workplace safety.
QUE Oncology is a privately held Melbourne-based clinical stage biotech company focused on innovative medicines to improve the tolerability of current anti-cancer treatments.
Queensland University of Technology (QUT) is a leading Australian university with a distinctive national and international reputation for combining academic strength and practical engagement with the professions, industry, government, and the broader community.
QuintilesIMS delivers integrated information and technology solutions to drive healthcare forward, globally. They work together with healthcare stakeholders to improve real-world patient outcomes through treatment innovations, care provision and access to healthcare.
To be able to conduct tests inexpensively, quickly and conveniently is the holy grail of sexually transmitted infections (STI) diagnostics and prevention.
Raven Consulting Group aims to help researchers (at universities, research institutes or within industry) to identify, obtain and maintain funding for their work.
Recce Limited (ASX: RCE) is pioneering the development and commercialisation of a new class of synthetic antibiotics with broad spectrum activity designed to address the urgent global health problem of antibiotic resistant superbugs. Its patented lead candidate known as RECCE® 327 is being developed for the treatment of sepsis derived from S. aureus and E. coli bacteria including their superbug forms.